Serbia is home to more than 7 million people, and is a potential Eastern Europe growth leader in the clinical trial market. Serbia has a diverse ethnic population in a promising pool of clinical trial participants, a centralized healthcare system, and record number of English-speaking professionals in the healthcare and clinical trial professions. Healthcare providers deliver high quality clinical trial data derived under GxP guidelines and can facilitate shorter study timelines.
This location opened in 2017 as the latest addition to the IMP portfolio.
Located in New Belgrade, in the Serbian capital.
National healthcare system provides universal country coverage.
Pharmaceutical license in place.
Location allows for delivery to sites within 24 hours of customs clearance.
Large quantities of investigational product (IP) and non-investigational medicinal product can be stored in the depot to handle peak enrollment needs and ensure drug availability.
Services include regulatory support; import/export permit; customs clearance coordination; storage in ambient and cold temperature zones; local distribution and logistics; comparator sourcing; equipment purchase/lease; and collection of returned IP and certified destruction.
Overall storage capacity of 350m3
Download the IMP Logistics Capabilities in Serbia Factsheet